RE: +13.78%6 Jul 2026 19:06
Four raises in a year, the share count up massively, and the price back near the lows. People can dress it up however they like, but plenty who bought into those raises are underwater now. The share price was up around 10p and now we’re sitting around 5p. That tells its own story. The issue for me is they keep adding projects but haven’t really delivered anything solid from the ones they already had. Eureka was meant to be the first proper proof point. We were supposed to get assays and then move towards a maiden JORC. We’re now in Q3 and still no assays, no JORC, no proper result. Instead, it looks like they’re now trying to sell it. Maybe they get a good deal, fair enough, but until the cash is actually in the bank it’s just more hope, sounds decent on paper, but it still needs approval, drilling and a lot more money. Paguanta has potential, but again needs money. Pereira Velho needs a JORC before the real value case opens up. Rachaite is another early-stage punt. It’s all “could be good one day”, but shareholders have heard enough of that now.
And these future payments are not just made-up deramping points. They are real commitments if Ajax wants to move these assets forward. So unless Eureka gets sold for proper money, where does the next chunk of cash come from? Probably another raise. That’s why the market is cautious. The Reveille situation doesn’t help either. If Ajax is supposedly about to turn the corner, why does it feel like the next story is already being pushed somewhere else? Ajax holders are still waiting for delivery here, not another shiny new vehicle. Get Eureka sold, get Macacha approved, get drilling done, get a JORC, get cash in. Until then, the share price is weak for a reason.